Back
AT&S Austria Technologie & Systemtechnik AG 10K Form
Sell
36
ASAAF
AT&S Austria Technologie & Systemtechnik AG
Last Price:
20.25
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ASAAF News And Ratings
See the #1 stock for the next 7 days that we like better than ASAAF
ASAAF Financial Statistics
Sales & Book Value
| Annual Sales: | $1.68B |
|---|---|
| Cash Flow: | $-294.87M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $28.16 |
| Price / Book: | 0.72 |
Profitability
| EPS (TTM): | -4.61840 |
|---|---|
| Net Income (TTM): | $-160.33M |
| Gross Margin: | $198.49M |
| Return on Equity: | -14.76% |
| Return on Assets: | -3.25% |
AT&S Austria Technologie & Systemtechnik AG Earnings Forecast
Key AT&S Austria Technologie & Systemtechnik AG Financial Ratios
- The Gross Profit Margin over the past 23 years for ASAAF is 11.80%.
- The Selling, General & Administrative Expenses for ASAAF have been equal to 7.38% of Gross Profit Margin.
- The Interest Expense is -183.08% of Operating Income.
- The Net Earning history of ASAAF is -2.37% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 13 years.
AT&S Austria Technologie & Systemtechnik AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Electronic Equipment, Instruments & Components |
| Sector: | Information Technology |
| Current Symbol: | ASAAF |
| Website: | ats.net |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.19 |
| Quick Ratio: | 1 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ASAAF Technical Analysis vs Fundamental Analysis
Sell
36
AT&S Austria Technologie & Systemtechnik AG (ASAAF)
is a Sell
Is AT&S Austria Technologie & Systemtechnik AG a Buy or a Sell?
-
AT&S Austria Technologie & Systemtechnik AG stock is rated a Sell
The current AT&S Austria Technologie & Systemtechnik AG [ASAAF] share price is $20.25. The Score for ASAAF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.